Personal information

Activities

Works (4)

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico

Vaccines
2025-01-16 | Journal article
Contributors: José Luis Huerta; Robyn Kendall; Luka Ivkovic; Carlos Molina; Amy W. Law; Diana Mendes
Source: check_circle
Crossref

Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK

International Journal of Chronic Obstructive Pulmonary Disease
2023-08 | Journal article
Contributors: Robyn Kendall; Alan A Martin; Dhvani Shah; Soham Shukla; Chris Compton; Afisi S Ismaila
Source: check_circle
Crossref

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

International Journal of Chronic Obstructive Pulmonary Disease
2022-10 | Journal article
Contributors: David MG Halpin; Robyn Kendall; Soham Shukla; Alan Martin; Dhvani Shah; Dawn Midwinter; Kai M Beeh; Janwillem WH Kocks; Paul W Jones; Chris Compton et al.
Source: check_circle
Crossref

Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model

International Journal of Chronic Obstructive Pulmonary Disease
2021-11 | Journal article
Contributors: Soham Shukla; Dhvani Shah; Alan Martin; Nancy A Risebrough; Robyn Kendall; Claus F Vogelmeier; Isabelle Boucot; Lee Tombs; Leif Bjermer; Paul W Jones et al.
Source: check_circle
Crossref